J&J’s Akeega Approved as First Combo Treatment for BRCA-Positive Prostate Cancer
XTalks
AUGUST 15, 2023
Akeega is approved for use with the corticosteroid prednisone in adults with BRCA1/2 mutations (germline and/or somatic) in whom chemotherapy is not clinically indicated. Niraparib is also sold by GSK under the name Zejula in other indications.
Let's personalize your content